We've found
3,204
archived clinical trials in
Healthy Studies
We've found
3,204
archived clinical trials in
Healthy Studies
Effect of Age and Weight Loss on Inflammation and Iron Homeostasis
Updated: 11/12/2015
Effect of Age and Weight Loss on Obesity-related Inflammation and Iron Homeostasis in Women
Status: Enrolling
Updated: 11/12/2015
Effect of Age and Weight Loss on Inflammation and Iron Homeostasis
Updated: 11/12/2015
Effect of Age and Weight Loss on Obesity-related Inflammation and Iron Homeostasis in Women
Status: Enrolling
Updated: 11/12/2015
Click here to add this to my saved trials
Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers
Updated: 11/12/2015
A Phase 1, Randomized, Subject- And Investigator-blind, Sponsor Open, Placebo Controlled, Single Ascending Dose Escalation Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Pf-04958242 Following Oral Dose Capsules in Healthy Subjects
Status: Enrolling
Updated: 11/12/2015
Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers
Updated: 11/12/2015
A Phase 1, Randomized, Subject- And Investigator-blind, Sponsor Open, Placebo Controlled, Single Ascending Dose Escalation Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Pf-04958242 Following Oral Dose Capsules in Healthy Subjects
Status: Enrolling
Updated: 11/12/2015
Click here to add this to my saved trials
Repeating Patterns of Sleep Restriction and Recovery
Updated: 11/13/2015
Repeating Patterns of Sleep Restriction and Recovery - do we Get Used to it?
Status: Enrolling
Updated: 11/13/2015
Repeating Patterns of Sleep Restriction and Recovery
Updated: 11/13/2015
Repeating Patterns of Sleep Restriction and Recovery - do we Get Used to it?
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
Evaluation of Bacillus Subtilis R0179 in Healthy Young Adults
Updated: 11/13/2015
Evaluation of Bacillus Subtilis R0179 in Capsules on Gastrointestinal Survival, Transit Time, Gastrointestinal Symptoms, and General Wellness in Healthy Young Adults
Status: Enrolling
Updated: 11/13/2015
Evaluation of Bacillus Subtilis R0179 in Healthy Young Adults
Updated: 11/13/2015
Evaluation of Bacillus Subtilis R0179 in Capsules on Gastrointestinal Survival, Transit Time, Gastrointestinal Symptoms, and General Wellness in Healthy Young Adults
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects
Updated: 11/17/2015
A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 Following Single Intravenous Dose Administration in Healthy Male Subjects
Status: Enrolling
Updated: 11/17/2015
A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects
Updated: 11/17/2015
A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 Following Single Intravenous Dose Administration in Healthy Male Subjects
Status: Enrolling
Updated: 11/17/2015
Click here to add this to my saved trials
A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males
Updated: 11/17/2015
A Randomized, Open Label, Four Period, Cross-Over Study to Evaluate the Pharmacokinetics of Single Doses of Various TRV734 Formulations in Healthy Male Subjects
Status: Enrolling
Updated: 11/17/2015
A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males
Updated: 11/17/2015
A Randomized, Open Label, Four Period, Cross-Over Study to Evaluate the Pharmacokinetics of Single Doses of Various TRV734 Formulations in Healthy Male Subjects
Status: Enrolling
Updated: 11/17/2015
Click here to add this to my saved trials
A Single Ascending Dose Study of PCO371 in Healthy Volunteers
Updated: 11/17/2015
A Randomized, Double-blind, Single Ascending Oral Dose Study To Evaluate Safety, Tolerability And Pharmacokinetics Of PCO371 In Healthy Volunteers
Status: Enrolling
Updated: 11/17/2015
A Single Ascending Dose Study of PCO371 in Healthy Volunteers
Updated: 11/17/2015
A Randomized, Double-blind, Single Ascending Oral Dose Study To Evaluate Safety, Tolerability And Pharmacokinetics Of PCO371 In Healthy Volunteers
Status: Enrolling
Updated: 11/17/2015
Click here to add this to my saved trials
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Updated: 11/18/2015
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Updated: 11/18/2015
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
Click here to add this to my saved trials
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Updated: 11/18/2015
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Updated: 11/18/2015
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
Click here to add this to my saved trials
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Updated: 11/18/2015
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Updated: 11/18/2015
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
Click here to add this to my saved trials
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Updated: 11/18/2015
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Updated: 11/18/2015
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
Click here to add this to my saved trials
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
Updated: 11/20/2015
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 11/20/2015
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
Updated: 11/20/2015
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 11/20/2015
Click here to add this to my saved trials
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
Updated: 11/20/2015
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 11/20/2015
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
Updated: 11/20/2015
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 11/20/2015
Click here to add this to my saved trials
A Study to Evaluate the Effect of ALKS 5461 on QT Intervals in Healthy Volunteers
Updated: 11/20/2015
The Effect of ALKS 5461 on QT Intervals in Healthy Volunteers
Status: Enrolling
Updated: 11/20/2015
A Study to Evaluate the Effect of ALKS 5461 on QT Intervals in Healthy Volunteers
Updated: 11/20/2015
The Effect of ALKS 5461 on QT Intervals in Healthy Volunteers
Status: Enrolling
Updated: 11/20/2015
Click here to add this to my saved trials
A Study of [¹⁴C]-LY3023414 in Healthy Participants
Updated: 11/20/2015
Disposition of [¹⁴C]-LY3023414 Following Oral Administration in Healthy Subjects
Status: Enrolling
Updated: 11/20/2015
A Study of [¹⁴C]-LY3023414 in Healthy Participants
Updated: 11/20/2015
Disposition of [¹⁴C]-LY3023414 Following Oral Administration in Healthy Subjects
Status: Enrolling
Updated: 11/20/2015
Click here to add this to my saved trials
Study of the Human Skin Microbiome
Updated: 11/24/2015
Study of the Human Skin Microbiome
Status: Enrolling
Updated: 11/24/2015
Study of the Human Skin Microbiome
Updated: 11/24/2015
Study of the Human Skin Microbiome
Status: Enrolling
Updated: 11/24/2015
Click here to add this to my saved trials
Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
Updated: 11/25/2015
Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 11/25/2015
Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
Updated: 11/25/2015
Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 11/25/2015
Click here to add this to my saved trials
Defining Vitamin D Insufficiency in School Age Children: A Randomized Placebo Controlled Trial of Vitamin D3
Updated: 11/30/2015
Defining Vitamin D Insufficiency in School Age Children: A Randomized Placebo Controlled Trial of Vitamin D3
Status: Enrolling
Updated: 11/30/2015
Defining Vitamin D Insufficiency in School Age Children: A Randomized Placebo Controlled Trial of Vitamin D3
Updated: 11/30/2015
Defining Vitamin D Insufficiency in School Age Children: A Randomized Placebo Controlled Trial of Vitamin D3
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Alcohol Exposure and Airway Hyperresponsiveness
Updated: 11/30/2015
Alcohol Exposure and Airway Hyperresponsiveness
Status: Enrolling
Updated: 11/30/2015
Alcohol Exposure and Airway Hyperresponsiveness
Updated: 11/30/2015
Alcohol Exposure and Airway Hyperresponsiveness
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Click here to add this to my saved trials
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Updated: 11/30/2015
Topcon 3D OCT-1 Maestro Reference Database Study II
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin
Updated: 12/1/2015
The Effects of Single-Dose Rifampin on the Pharmacokinetics of Rosuvastatin in Healthy White and Asian Volunteers
Status: Enrolling
Updated: 12/1/2015
The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin
Updated: 12/1/2015
The Effects of Single-Dose Rifampin on the Pharmacokinetics of Rosuvastatin in Healthy White and Asian Volunteers
Status: Enrolling
Updated: 12/1/2015
Click here to add this to my saved trials
Modified Consent Form Utility
Updated: 12/1/2015
CTSA Utility of Modified Consent Forms in Clinical Research: Fraga Tea Study
Status: Enrolling
Updated: 12/1/2015
Modified Consent Form Utility
Updated: 12/1/2015
CTSA Utility of Modified Consent Forms in Clinical Research: Fraga Tea Study
Status: Enrolling
Updated: 12/1/2015
Click here to add this to my saved trials
Development of Inflammatory Disease Model Protein, Genetic and Microbial Biomarkers
Updated: 12/1/2015
Development of Inflammatory Disease Model Protein, Genetic and Microbial Biomarkers
Status: Enrolling
Updated: 12/1/2015
Development of Inflammatory Disease Model Protein, Genetic and Microbial Biomarkers
Updated: 12/1/2015
Development of Inflammatory Disease Model Protein, Genetic and Microbial Biomarkers
Status: Enrolling
Updated: 12/1/2015
Click here to add this to my saved trials
Brief Behavioral Treatment for Anxiety in Young Children
Updated: 12/2/2015
A Brief Behavioral Treatment for Anxiety in Young Children
Status: Enrolling
Updated: 12/2/2015
Brief Behavioral Treatment for Anxiety in Young Children
Updated: 12/2/2015
A Brief Behavioral Treatment for Anxiety in Young Children
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
Updated: 12/2/2015
A Feasibility Study for a Phase 3, Randomized, Four-Week, Double-Blind, Placebo-Controlled, Crossover Trial of the Efficacy and Safety of PH94B Nasal Spray in the Acute Treatment of Social Anxiety Disorder (SAD)
Status: Enrolling
Updated: 12/2/2015
Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
Updated: 12/2/2015
A Feasibility Study for a Phase 3, Randomized, Four-Week, Double-Blind, Placebo-Controlled, Crossover Trial of the Efficacy and Safety of PH94B Nasal Spray in the Acute Treatment of Social Anxiety Disorder (SAD)
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
Updated: 12/3/2015
Quantitative Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking the Antipsychotic Medications Fanapt (Iloperidone) or Zyprexa (Olanzapine) or Placebo
Status: Enrolling
Updated: 12/3/2015
Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
Updated: 12/3/2015
Quantitative Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking the Antipsychotic Medications Fanapt (Iloperidone) or Zyprexa (Olanzapine) or Placebo
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
A Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers
Updated: 12/3/2015
A Phase 1 Open-Label, Radiolabeled, Single-Dose Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers
Status: Enrolling
Updated: 12/3/2015
A Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers
Updated: 12/3/2015
A Phase 1 Open-Label, Radiolabeled, Single-Dose Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
Validation of an Assay to Measure Cyclooxygenase-1 Activity
Updated: 12/4/2015
Validation of an Ex Vivo Cyclooxygenase-1 Catalytic Assay in Humans
Status: Enrolling
Updated: 12/4/2015
Validation of an Assay to Measure Cyclooxygenase-1 Activity
Updated: 12/4/2015
Validation of an Ex Vivo Cyclooxygenase-1 Catalytic Assay in Humans
Status: Enrolling
Updated: 12/4/2015
Click here to add this to my saved trials
Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers
Updated: 12/7/2015
A Double Blind, Randomized, Single Dose, Placebo Controlled Study of the Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers
Status: Enrolling
Updated: 12/7/2015
Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers
Updated: 12/7/2015
A Double Blind, Randomized, Single Dose, Placebo Controlled Study of the Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers
Status: Enrolling
Updated: 12/7/2015
Click here to add this to my saved trials
Promoting Healthy Lifestyles Using Mobile Phones
Updated: 12/8/2015
Promoting Healthy Lifestyles Using Mobile Phones
Status: Enrolling
Updated: 12/8/2015
Promoting Healthy Lifestyles Using Mobile Phones
Updated: 12/8/2015
Promoting Healthy Lifestyles Using Mobile Phones
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers
Updated: 12/8/2015
A Single-Dose, Open-Label, Randomized, Food Effect Study in Healthy Volunteers With PT2385 Tablets
Status: Enrolling
Updated: 12/8/2015
PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers
Updated: 12/8/2015
A Single-Dose, Open-Label, Randomized, Food Effect Study in Healthy Volunteers With PT2385 Tablets
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Computer-Based Physical Activity Advice for Ethnic Minority Aging Adults
Updated: 12/8/2015
Computer-Based Physical Activity Advice for Ethnic Minority Aging Adults
Status: Enrolling
Updated: 12/8/2015
Computer-Based Physical Activity Advice for Ethnic Minority Aging Adults
Updated: 12/8/2015
Computer-Based Physical Activity Advice for Ethnic Minority Aging Adults
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants
Updated: 12/9/2015
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Safety, Tolerability, and Pharmacokinetic Study in Healthy Subjects After Multiple Oral Doses of TAK-058
Status: Enrolling
Updated: 12/9/2015
Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants
Updated: 12/9/2015
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Safety, Tolerability, and Pharmacokinetic Study in Healthy Subjects After Multiple Oral Doses of TAK-058
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
Updated: 12/9/2015
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (Short Title (HOP-3)
Status: Enrolling
Updated: 12/9/2015
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
Updated: 12/9/2015
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (Short Title (HOP-3)
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Food Effect Study of AG-221 in Healthy Male Subjects
Updated: 12/11/2015
A Phase 1, Two-Way Crossover Study to Assess the Pharmacokinetics and Safety of a Single Dose of AG-221 in Healthy Male Subjects When Administered Under Fed and Fasted Conditions
Status: Enrolling
Updated: 12/11/2015
Food Effect Study of AG-221 in Healthy Male Subjects
Updated: 12/11/2015
A Phase 1, Two-Way Crossover Study to Assess the Pharmacokinetics and Safety of a Single Dose of AG-221 in Healthy Male Subjects When Administered Under Fed and Fasted Conditions
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120
Updated: 12/11/2015
A Phase 1, Open-label Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120 Following Single Oral Dose Administration in Healthy Male Subjects
Status: Enrolling
Updated: 12/11/2015
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120
Updated: 12/11/2015
A Phase 1, Open-label Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120 Following Single Oral Dose Administration in Healthy Male Subjects
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
Integrated Microfluidic System for Oral Diagnostics
Updated: 12/11/2015
Integrated Microfluidic System for Oral Diagnostics
Status: Enrolling
Updated: 12/11/2015
Integrated Microfluidic System for Oral Diagnostics
Updated: 12/11/2015
Integrated Microfluidic System for Oral Diagnostics
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress
Updated: 12/11/2015
The Effect of Intermittent Fasting on Adaptive Oxidative Stress Response and Mitochondrial Biogenesis
Status: Enrolling
Updated: 12/11/2015
Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress
Updated: 12/11/2015
The Effect of Intermittent Fasting on Adaptive Oxidative Stress Response and Mitochondrial Biogenesis
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
TEAM: Testosterone Supplementation and Exercise in Elderly Men
Updated: 12/14/2015
Testosterone Supplementation and Exercise in Elderly Men
Status: Enrolling
Updated: 12/14/2015
TEAM: Testosterone Supplementation and Exercise in Elderly Men
Updated: 12/14/2015
Testosterone Supplementation and Exercise in Elderly Men
Status: Enrolling
Updated: 12/14/2015
Click here to add this to my saved trials
Self-Directed Biological Transformation Initiative
Updated: 12/14/2015
Self-Directed Biological Transformation Initiative
Status: Enrolling
Updated: 12/14/2015
Self-Directed Biological Transformation Initiative
Updated: 12/14/2015
Self-Directed Biological Transformation Initiative
Status: Enrolling
Updated: 12/14/2015
Click here to add this to my saved trials
A Study of [¹⁴C]-LY3202626 in Healthy Male Participants
Updated: 12/15/2015
Disposition of [¹⁴C]-LY3202626 Following Oral Administration in Healthy Male Subjects
Status: Enrolling
Updated: 12/15/2015
A Study of [¹⁴C]-LY3202626 in Healthy Male Participants
Updated: 12/15/2015
Disposition of [¹⁴C]-LY3202626 Following Oral Administration in Healthy Male Subjects
Status: Enrolling
Updated: 12/15/2015
Click here to add this to my saved trials
Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
Updated: 12/16/2015
Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
Status: Enrolling
Updated: 12/16/2015
Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
Updated: 12/16/2015
Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
Status: Enrolling
Updated: 12/16/2015
Click here to add this to my saved trials
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
Updated: 12/17/2015
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate.
Status: Enrolling
Updated: 12/17/2015
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
Updated: 12/17/2015
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate.
Status: Enrolling
Updated: 12/17/2015
Click here to add this to my saved trials